Publications by authors named "A Compadre"

Claim this Profile
T
Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancers.
Lindsey N Aubuchon, Deanna H Wong, Natasha M Ramakrishnan, Rohan Reddy, Amanda Compadre

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provider insights to improve colposcopy adherence and feasibility of a social needs navigator program.
Amanda J Compadre, Rachel Paul, Alexis Allihien, Rida Qureshi, Sarah Badwan

Am J Obstet Gynecol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Angela Schab, Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez

J Clin Invest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Angela Schab, Amanda Compadre, Rikki Drexler, Maggie Loeb, Kevin Rodriguez

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From raw microalgae to bioplastics: Conversion of Chlorella vulgaris starch granules into thermoplastic starch.
A Six, D Dauvillée, C Lancelon-Pin, A Dimitriades-Lemaire, A Compadre

Carbohydr Polym· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis